These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1731707)

  • 41. Chlorpromazine-induced corneal toxicity.
    Koh V; Khor WB; Lim L
    Arch Ophthalmol; 2012 Nov; 130(11):1409. PubMed ID: 23143440
    [No Abstract]   [Full Text] [Related]  

  • 42. Negligible hepatotoxicity of chlorpromazine in long-term therapy.
    Weinreb M; Kraus V; Krausová J; Hudcová T
    Act Nerv Super (Praha); 1978 Dec; 20(4):280-1. PubMed ID: 735735
    [No Abstract]   [Full Text] [Related]  

  • 43. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema.
    Harbour JW; Smiddy WE; Rubsamen PE; Murray TG; Davis JL; Flynn HW
    Am J Ophthalmol; 1995 Sep; 120(3):302-7. PubMed ID: 7661201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Syndrome of inappropriate secretion of antidiuretic hormone in association with chlorpromazine ingestion.
    Tildesley HD; Toth E; Crockford PM
    Can J Psychiatry; 1983 Oct; 28(6):487-8. PubMed ID: 6640486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Beijing Eye Study.
    Jonas JB; Xu L; Wang YX
    Acta Ophthalmol; 2009 May; 87(3):247-61. PubMed ID: 19426355
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pseudo-exfoliative syndrome. 2: Semiology and physiological variations of pigment dispersion].
    Clergeau G
    Bull Soc Ophtalmol Fr; 1985 Nov; 85(11):1197-9. PubMed ID: 3843183
    [No Abstract]   [Full Text] [Related]  

  • 47. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 48. Pseudoexfoliation syndrome--case report and review of clinical features.
    Kim YJ; Park MG; Choi WJ
    Korean J Ophthalmol; 1990 Dec; 4(2):108-11. PubMed ID: 2092161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of the ocular reactions to microfilaricides in the chemotherapy of onchocerciasis.
    Hero M; Bird AC; Awadzi K
    Eye (Lond); 1992; 6 ( Pt 1)():93-6. PubMed ID: 1426410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pseudoexfoliation syndrome in Chinese.
    Ye TC; Mao WS; Zhang J
    Jpn J Ophthalmol; 1989; 33(3):300-10. PubMed ID: 2796010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Congenital duplication of the anterior segment with central hamartomatous plaque.
    Mouriaux F; Leroy-Rattier MP; Maurage CA; Guilbert F; Cree I; Rouland JF
    Arch Ophthalmol; 2002 Oct; 120(10):1377-9. PubMed ID: 12365920
    [No Abstract]   [Full Text] [Related]  

  • 52. Chlorpromazine induced fluid retention masquerading as idiopathic oedema.
    Witz L; Shapiro MS; Shenkman L
    Br Med J (Clin Res Ed); 1987 Mar; 294(6575):807-8. PubMed ID: 3105751
    [No Abstract]   [Full Text] [Related]  

  • 53. [A double-blind controlled study of the efficacy and side effects of thioridazine and chlorpromazine in schizophrenia].
    Guo GY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):300-2, 319-20. PubMed ID: 3234163
    [No Abstract]   [Full Text] [Related]  

  • 54. Chlorpromazine-induced severe skin pigmentation and corneal opacities in a patient with schizophrenia.
    Molina-Ruiz AM; Pulpillo Á; Molina-Ruiz RM; Sagrario T; Requena L
    Int J Dermatol; 2016 Aug; 55(8):909-12. PubMed ID: 26340849
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pseudo-exfoliative syndrome. 1: Semiology and clinical variations of pseudo-exfoliation].
    Clergeau G
    Bull Soc Ophtalmol Fr; 1985 Nov; 85(11):1191-6. PubMed ID: 3843182
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolic studies of chlorpromazine induced hyperpigmentation of the skin in psychiatric patients.
    Bolt AG; Forrest IS
    Agressologie; 1968; 9(2):201-7. PubMed ID: 5675487
    [No Abstract]   [Full Text] [Related]  

  • 57. Fibrosis in the anterior segments of the eye.
    Yamanaka O; Liu CY; Kao WW
    Endocr Metab Immune Disord Drug Targets; 2010 Dec; 10(4):331-5. PubMed ID: 20925651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationships among clinical response, extrapyramidal syndrome and plasma chlorpromazine and metabolite ratios.
    Sakalis G; Chan TL; Sathananthan G; Schooler N; Goldberg S; Gershon S
    Commun Psychopharmacol; 1977; 1(2):157-66. PubMed ID: 342185
    [No Abstract]   [Full Text] [Related]  

  • 59. Eye and skin changes in psychiatric patients treated with chlorpromazine.
    Mathalone MB
    Br J Ophthalmol; 1967 Feb; 51(2):86-93. PubMed ID: 6018911
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term changes in AIMS ratings and their relation to medication history [proceedings].
    Smith JM; Burke MP; Moon CO
    Psychopharmacol Bull; 1981 Jan; 17(1):120-1. PubMed ID: 7232640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.